<DOC>
	<DOCNO>NCT00637741</DOCNO>
	<brief_summary>The objective clinical investigation evaluate long-term ( 12 month ) outcome 200 mm long self-expanding nitinol EverFlex ( ev3 ) stent long femoropopliteal lesion ( TASC C &amp; D ) Is first time use 200 mm long stent evaluate lesion . It expect outcome treatment type long stent well treatment identical lesion lengths multiple short stent .</brief_summary>
	<brief_title>DURABILITY-200 : EverFlex 200mm Long Nitinol Stents TASC C &amp; D Femoropopliteal Lesions</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>GENERAL De novo , restenotic reoccluded lesion locate femoropopliteal artery suitable stenting Patient present score 2 5 follow Rutherford classification Patient willing comply specify followup evaluation specify time Patient &gt; 18 year old Patient ( legal representative ) understand nature procedure provide write informed consent , prior enrolment study Prior enrollment , guidewire cross target lesion Patient eligible treatment selfexpanding nitinol EverFlex ( ev3 ) stent ANGIOGRAPHIC The target lesion locate within native femoropopliteal artery maximally 3 cm proximally knee joint . The target lesion angiographic evidence stenosis restenosis &gt; 50 % occlusion pass standard guidewire manipulation The target lesion , visually estimate , minimal length 15 cm categorize either type C D lesion accord TASC II guideline Target vessel diameter visually estimate &gt; 4mm &lt; 6.5 mm There angiographic evidence least onevesselrunoff foot Presence another stent target vessel place previous procedure Presence aortic thrombosis significant common femoral ipsilateral stenosis Previous bypass surgery limb Patients antiplatelet therapy , anticoagulant thrombolytic drug contraindicate Patients exhibit persistent acute intraluminal thrombus propose lesion site Perforation angioplasty site evidence extravasation contrast medium Patients know hypersensitivity nickeltitanium Patients uncorrected bleed disorder Aneurysm locate level SFA Female patient child bear potential take adequate contraceptive currently breastfeed Life expectancy less twelve month Ipsilateral iliac treatment target lesion procedure residual stenosis &gt; 30 % ipsilateral iliac treatment conduct target lesion procedure Use thrombectomy , artherectomy laser device procedure Any planned surgical intervention/procedure within 30 day study procedure Any patient consider hemodynamically unstable onset procedure Patient currently participate another investigational drug device study complete entire follow period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Intermittent claudication</keyword>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>TASC</keyword>
</DOC>